Gareth W Langley, Martine I Abboud, Christopher T Lohans, Christopher J Schofield
Bioorganic & medicinal chemistry 2019 Jun 15The hydroxylation of prolyl-residues in eukaryotes is important in collagen biosynthesis and in hypoxic signalling. The hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs) are drug targets for the treatment of anaemia, while the procollagen prolyl hydroxylases and other 2-oxoglutarate dependent oxygenases are potential therapeutic targets for treatment of cancer, fibrotic disease, and infection. We describe assay development and inhibition studies for a procollagen prolyl hydroxylase from Paramecium bursaria chlorella virus 1 (vCPH). The results reveal HIF PHD inhibitors in clinical trials also inhibit vCPH. Implications for the targeting of the human PHDs and microbial prolyl hydroxylases are discussed. Copyright © 2019. Published by Elsevier Ltd.
Gareth W Langley, Martine I Abboud, Christopher T Lohans, Christopher J Schofield. Inhibition of a viral prolyl hydroxylase. Bioorganic & medicinal chemistry. 2019 Jun 15;27(12):2405-2412
PMID: 30737136
View Full Text